M. S. Roost, “Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities”, J Pharm Pharm Sci, vol. 24, pp. 548–562, Oct. 2021.